ShortageRadar
ANN · 97.91% Acc
Medicine Shortage Intelligence

Predict shortages before they reach your patients.

Forward-looking risk across the UK, USA, Italy and Belgium — powered by a trained artificial neural network.
Last model run
High Risk
predictions ≥75%
Medium Risk
50–75% band
Active Shortages
currently reported
Active Predictions
within horizon
Countries
affected now
Model Accuracy
97.9%
dissertation ANN

Flintweb Intelligence

Generated from current dashboard data

Shortage Trend

Reported shortages by month

Top Shortage Causes

Share of recorded shortages

Country Risk

Active shortages & average predicted risk

Highest-Risk Medicines

Top forward-looking predictions
MedicineCountryTop causeHorizonConfidenceRisk
Forward-looking

Predictions

Every medicine-and-country pairing currently flagged at risk, highest first.

Risk Predictions

MedicineCountryTop causeHorizonConfidenceRisk

Currently Active Shortages

Reported, ongoing
MedicineCountryCauseSinceStatus
Geographic view

Countries

Where shortages are concentrated and how predicted risk compares.

Active Shortages by Country

Currently reported
Stay ahead

Get shortage alerts

Receive an email when a medicine you track moves into a high-risk band.
We'll only email you about shortage risk. Unsubscribe anytime.
Research foundation

About ShortageRadar

ShortageRadar turns medicine-shortage management from reactive into predictive. Today, national systems issue an alert only once a supplier reports a disruption. ShortageRadar applies a trained artificial neural network to historical supply data and scores each medicine-and-country pairing for shortage risk over a forward horizon — surfacing the medicines most likely to enter shortage while there is still time to act.

97.91%
Model accuracy
1.00
Shortage recall
11,655
WHO MSRS records
4
Nations modelled

Methodology

The model was developed on World Health Organization Medicines Shortage Reporting System data spanning the United Kingdom, United States, Italy and Belgium — learning the patterns that historically preceded shortages: vulnerable drug categories and forms, recurring root causes, seasonality and cross-border signals. On held-out evaluation it achieved 97.91% accuracy with 1.00 recall on shortage events — meaning it missed none of the true shortages in the test data.

Provenance

Built on original MSc dissertation research — Predictive Big Data Analytics for the Prediction and Prevention of Medicine Shortages — conducted at the University of Bradford School of Management by Adeshina Akande, Flintweb Global Resources Ltd, supervised by Dr Emilia Vann Yaroson.

Current build is a research demonstrator scoring historical WHO MSRS data. Roadmap: live regulatory-feed ingestion (NHS, DHSC, FDA, AIFA, FAMHP) with continuous re-scoring and prospective validation. Independent product by Flintweb Global Resources Ltd; not affiliated with or endorsed by the NHS.